Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell and Tissue-Based Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT05473923
What this trial is testing

PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas

Who this might be right for
Recurrent High Grade Glioma
Beijing Tiantan Hospital 30
Not applicableStudy completedNCT01938014
What this trial is testing

Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children

Who this might be right for
Mucopolysaccharidosis Type I (MPS I)Mucopolysaccharidosis Type II (MPS II)Mucopolysaccharidosis Type III (MPS III)+2 more
University of Chicago 19
Large-scale testing (Phase 3)Study completedNCT00003032
What this trial is testing

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 224
Not applicableEnded earlyNCT05435352
What this trial is testing

Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment

Who this might be right for
Triple Negative Breast CancerTriple Negative Breast Neoplasms
Ourotech, Inc. 34
Not applicableWithdrawnNCT02580136
What this trial is testing

Esthesioneuroblastoma: Outcomes After Treatment

Who this might be right for
Esthesioneuroblastoma, Olfactory
Ricardo L. Carrau, MD
Early research (Phase 1)Study completedNCT00822458
What this trial is testing

GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment

Who this might be right for
Recurrent Childhood Medulloblastoma
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT01118078
What this trial is testing

Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more
Children's Oncology Group 185
Not applicableUnknownNCT04792437
What this trial is testing

Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data

Who this might be right for
TranscriptomicsRadiomicsGlioma
Yu Yao, MD 120
Not applicableTemporarily pausedNCT04219475
What this trial is testing

Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
OncoHost Ltd. 1,000
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Early research (Phase 1)Study completedNCT00001535
What this trial is testing

Twins Study of Gene Therapy for HIV Infection

Who this might be right for
Acquired Immunodeficiency SyndromeHIV InfectionKaposi's Sarcoma
National Human Genome Research Institute (NHGRI) 48
Early research (Phase 1)Ended earlyNCT03186417
What this trial is testing

Mesenchymal Stem Cells in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
MetroHealth Medical Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05724108
What this trial is testing

Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors

Who this might be right for
Metastatic Neuroendocrine Tumor
National Cancer Institute (NCI) 94
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Testing effectiveness (Phase 2)Study completedNCT00357396
What this trial is testing

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT00436254
What this trial is testing

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

Who this might be right for
HER2-positive Breast CancerStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell Tumor+6 more
University of Washington 66
Large-scale testing (Phase 3)Study completedNCT00055562
What this trial is testing

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
Celgene Corporation 274
Not applicableUnknownNCT04136470
What this trial is testing

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Who this might be right for
Non Small Cell Lung CancerMicrobiomeMetagenome+2 more
Ardigen 130
Testing effectiveness (Phase 2)Study completedNCT00114140
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 136
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Next Page